MARKET

ECOR

ECOR

Electrocore
NASDAQ
5.65
+0.01
+0.18%
After Hours: 5.65 -0.18 -3.09% 16:00 04/19 EDT
OPEN
5.76
PREV CLOSE
5.64
HIGH
6.34
LOW
5.65
VOLUME
7.41K
TURNOVER
0
52 WEEK HIGH
8.08
52 WEEK LOW
3.829
MARKET CAP
33.91M
P/E (TTM)
-1.6544
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ECOR last week (0408-0412)?
Weekly Report · 5d ago
Weekly Report: what happened at ECOR last week (0401-0405)?
Weekly Report · 04/08 11:47
electroCore Announces the Launch of Truvaga Plus® for General Wellness
Barchart · 04/08 07:30
electroCore Expands Intellectual Property Portfolio With Two New Patents, "No. 11,944,815" And "No. 11,944,807"
ElectroCore, Inc. Has received two patents from the U.S. Patent and Trademark Office. The two patents relate to electroCore's non-invasive vagus nerve stimulation technology. ElectroCore is a commercial-stage bioelectronic medicine and wellness company.
Benzinga · 04/02 12:18
Weekly Report: what happened at ECOR last week (0325-0329)?
Weekly Report · 04/01 11:43
Weekly Report: what happened at ECOR last week (0318-0322)?
Weekly Report · 03/25 11:47
Weekly Report: what happened at ECOR last week (0311-0315)?
Weekly Report · 03/18 11:45
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)
TipRanks · 03/15 11:40
More
About ECOR
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

Webull offers electroCore, Inc. stock information, including NASDAQ: ECOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ECOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ECOR stock methods without spending real money on the virtual paper trading platform.